Financhill
Back

Enphase Energy Vs. Summit Therapeutics Industry Stock Comparison

Sell
28

ENPH
Enphase Energy

Last Price:
$65.43
Seasonality Move:
21.58%
Sell
46

SMMT
Summit Therapeutics

Last Price:
$16.66
Seasonality Move:
7.78%
Sell
28
Enphase Energy (ENPH) is a Sell

Is Enphase Energy a Buy, Sell or Hold?

  • The current Enphase Energy [ENPH] share price is $65.45. The Score for ENPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ENPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $16.65. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENPH Stock Price Chart

What is Enphase Energy's stock price today?

  • The Enphase Energy share price today is $65.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENPH is experiencing selling pressure, which indicates risk of future bearish movement.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $16.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

ENPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 39.3 Sell
Chaikin Money Flow: -2684912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.48 - 74.08) Sell
Bollinger Bands (100): (68.31 - 109.33) Sell

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 40.61 Sell
Chaikin Money Flow: -2642249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.6 - 18.78) Sell
Bollinger Bands (100): (15.7 - 22.62) Sell

ENPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.64 Sell
20-day SMA: 70.62 Sell
50-day SMA: 70.83 Sell
200-day SMA: 101.37 Sell
8-day EMA: 68.64 Sell
20-day EMA: 70.21 Sell
50-day EMA: 74.79 Sell
200-day EMA: 97.13 Sell

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.96 Sell
20-day SMA: 18.15 Sell
50-day SMA: 18.76 Sell
200-day SMA: 13.03 Buy
8-day EMA: 17.83 Sell
20-day EMA: 18.12 Sell
50-day EMA: 18.46 Sell
200-day EMA: 14.25 Buy

Enphase Energy Earnings Growth & ENPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.57 per share, and an increase next year of $1.01 per share.

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.

Enphase Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):